skip to Main Content
AIONX® Satellite Symposium At The American Burn Association’s 50th Annual Meeting, April 10-13, 2018

AIONX® Satellite Symposium at the American Burn Association’s 50th Annual Meeting, April 10-13, 2018

The American Burn Association (ABA) seeks to bring awareness about how burn injuries are caused and how making simple environmental and behavioral changes can save lives.

Burn injuries are one of the most challenging healthcare issues to both patients and caregivers. In the United States and Canada, over 450,000 individuals are seen in emergency departments, clinics or physicians’ offices for the treatment of burn injuries [1]. There are 40,000 hospitalizations related to burn injuries, including 30,000 at hospital burn centers [2]. Within burn centers, infections top the list of the most common complications, making the prevention and treatment of infectious diseases a central focus of burn care teams.

AIONX® supports the ABA’s mission and believes our innovative products and services, that utilize cutting-edge technology, can help. AIONX® attended the American Burn Association’s 50th Annual Meeting in Chicago, April 10-13, and hosted a Satellite Symposium to discuss how the AIONX® CleanSurface™ Covers could help burn care teams provide cleaner, better care.

Sources: 

  1. Prevention. Retrieved from http://ameriburn.org/prevention/
  2. Burn Incidence Fact Sheet. Retrieved from http://ameriburn.org/who-we-are/media/burn-incidence-fact-sheet/
  3. Coban, Yusuf Kenan. “Infection Control in Severely Burned Patients.” World Journal of Critical Care Medicine 1.4 (2012): 94–101. PMC. Web. 2 Mar. 2018.

* The AIONX Surface Covers use the AIONX® technology, which is registered with the EPA (EPA Reg. No. 91681-1) as an antimicrobial agent that effectively inhibits the growth of bacteria, fungi, algae, mold, and mildew that cause unpleasant odors, discoloration, staining, deterioration or corrosion on surfaces to which it is applied. The EPA has not reviewed or approved, nor does AIONX® make, any claims that its technology has efficacy against any particular pathogenic microbes. The use of AIONX® technology at a use site is a supplement to and not a substitute for standard infection control practices; users must continue to follow all current infection control practices, including those practices related to cleaning and disinfection of environmental surfaces.